Skip to search formSkip to main contentSkip to account menu

p17 gag peptide, human immunodeficiency virus

Known as: SLYNTVATL, serine-leucyl-tyrosyl-asparagyl-threonyl-valyl-alanyl-threonyl-leucine, HIV Gag p17 (77-85) 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
HLA‐B57 has been shown to be associated with long‐term asymptomatic HIV‐1 infection. To investigate the biological mechanism by… 
Highly Cited
2004
Highly Cited
2004
ABSTRACT Investigating escape mechanisms of human immunodeficiency virus type 1 (HIV-1) from cytotoxic T lymphocytes (CTLs) is… 
Highly Cited
2004
Highly Cited
2004
All thymically selected T cells are inherently cross-reactive, yet many data indicate a fine specificity in antigen recognition… 
Highly Cited
2002
Highly Cited
2002
ABSTRACT Following the introduction of highly active antiretroviral therapy (HAART), the incidence of Kaposi's sarcoma (KS) has… 
Highly Cited
2000
Highly Cited
2000
The functional status of circulating human immunodeficiency (HIV)-specific CD8 T cells in chronically infected subjects was… 
Highly Cited
2000
Highly Cited
2000
ABSTRACT Recent studies of human immunodeficiency virus (HIV)-specific CD8+ T cells have focused on responses to single, usually… 
1999
1999
To address the issue of clonal exhaustion in humans, we monitored HLA class I-restricted, epitope-specific CTL responses in an in… 
Highly Cited
1995
Highly Cited
1995
Initial studies suggested that major histocompatibility complex class I-restricted viral epitopes could be predicted by the… 
Highly Cited
1994
Highly Cited
1994
We have established long-term cultures of several cell lines stably and uniformly expressing human immunodeficiency virus type 1…